4.7 Review

Regulatory dendritic cells in the tumor immunoenvironment

期刊

CANCER IMMUNOLOGY IMMUNOTHERAPY
卷 61, 期 2, 页码 223-230

出版社

SPRINGER
DOI: 10.1007/s00262-011-1138-8

关键词

Dendritic cells; Tumor microenvironment; Immunosuppression; Immune tolerance; Regulatory myeloid cells; CITIM 2011

资金

  1. CCR NIH HHS [HHSN261200800001C] Funding Source: Medline
  2. NCI NIH HHS [R01 CA154369-01A1, R01 CA154369, HHSN261200800001E] Funding Source: Medline

向作者/读者索取更多资源

The tumor microenvironment is a pivotal factor in tumorigenesis, and especially in progression, as the pathogenesis of cancer critically depends on the complex interactions between various microenvironmental components. A key component of the tumor immunoenvironment is the infiltration of immune cells, which has been proven to play a dual role in tumor growth and progression. This Janus two-faced function of the tumor immunoenvironment is seen in tumor infiltration by T cells, which correlates with improved patient survival, but also with the homing of multiple subsets of immunoregulatory cells that inhibit the antitumor immune response. Regulatory dendritic cells (regDCs) have recently been shown to be induced by tumor-derived factors and represent a new and potentially important player in supporting tumor progression and suppressing the development of antitumor immune responses. Our recent data reveal that different tumor cell lines produce soluble factors that induce polarization of conventional DCs into regDCs, both in vitro and in vivo. These regDCs can suppress the proliferation of pre-activated T cells and are phenotypically and functionally different from their precursors as well as the classical immature conventional DCs. Understanding the biology of regDCs and the mechanisms of their formation in the tumor immunoenvironment will provide a new therapeutic target for re-polarizing protumorigenic immunoregulatory cells into proimmunogenic effector cells able to induce and support effective antitumor immunity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Schwann cells: a new player in the tumor microenvironment

Yuri L. Bunimovich, Anton A. Keskinov, Galina V. Shurin, Michael R. Shurin

CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)

Editorial Material Medicine, Research & Experimental

Osteopontin controls immunosuppression in the tumor microenvironment

Michael R. Shurin

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Oncology

Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth

Galina V. Shurin, Oleg Kruglov, Fei Ding, Yan Lin, Xingxing Hao, Anton A. Keskinov, Zhaoyang You, Anna E. Lokshin, William A. LaFramboise, Louis D. Falo, Michael R. Shurin, Yuri L. Bunimovich

CANCER RESEARCH (2019)

Article Biochemistry & Molecular Biology

Abnormal Expression of c-Myc Oncogene in NK Cells in Patients with Cancer

Gulnur K. Zakiryanova, Elena Kustova, Nataliya T. Urazalieva, Emile T. Baimuchametov, Narymzhan N. Nakisbekov, Michael R. Shurin

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Immunology

The Neuroimmune Axis in the Tumor Microenvironment

Michael R. Shurin, Galina V. Shurin, Samuel B. Zlotnikov, Yuri L. Bunimovich

JOURNAL OF IMMUNOLOGY (2020)

Article Oncology

Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma

Deena M. Maurer, Juraj Adamik, Patricia M. Santos, Jian Shi, Michael R. Shurin, John M. Kirkwood, Walter J. Storkus, Lisa H. Butterfield

CANCER IMMUNOLOGY RESEARCH (2020)

Review Cell Biology

Neuroimmune Regulation of Surgery-Associated Metastases

Michael R. Shurin, James H. Baraldi, Galina V. Shurin

Summary: Surgery can promote cancer metastasis through mechanisms such as the release of neuroendocrine hormones, immunosuppression, neovascularization, and tissue remodeling. The role of neuroimmune regulation in surgery-associated metastasis is not well understood, highlighting the need for further research in this area.
Article Medical Laboratory Technology

Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies

Nathan Cook, Lingqing Xu, Shaymaa Hegazy, Bradley J. Wheeler, Adam R. Anderson, Nancy Critelli, Mary Yost, Anita K. McElroy, Michael R. Shurin, Sarah E. Wheeler

Summary: The study aimed to detect antibodies to different SARS-CoV-2 antigens, analyzing the performance of the BioRad SARS-CoV-2 IgG multiplex assay in terms of diagnostic accuracy, differentiation of vaccination and natural disease, and retrospective exposure determination. Results showed that the assay is comparable to existing methods, achieving 100% sensitivity when all markers are included, with practical implications for research and infection prevention strategies.

CLINICAL BIOCHEMISTRY (2021)

Article Microbiology

Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects

Sarah E. Wheeler, Galina Shurin, Mary Yost, Adam Anderson, Lisa Pinto, Alan Wells, Michael R. Shurin

Summary: Understanding the development and duration of virus-specific antibodies after COVID-19 vaccination is important for controlling the pandemic. Postvaccination antibody testing can help in monitoring individuals after vaccination and selecting those who may require additional doses or not need vaccination.

MICROBIOLOGY SPECTRUM (2021)

Article Microbiology

A Cross-Sectional Study of SARS-CoV-2 Seroprevalence between Fall 2020 and February 2021 in Allegheny County, Western Pennsylvania, USA

Lingqing Xu, Joshua Doyle, Dominique J. Barbeau, Valerie Le Sage, Alan Wells, W. Paul Duprex, Michael R. Shurin, Sarah E. Wheeler, Anita K. McElroy

Summary: This study found a 4.5-fold increase in SARS-CoV-2 seroprevalence from Fall 2020 to February 2021 in Allegheny County, Pennsylvania, due to increased incidence of both natural disease and vaccination. The neutralization titer was significantly correlated with RBD titer but not with N titer. In the February cohort, higher median income and white race were associated with serological findings consistent with vaccination.

PATHOGENS (2021)

Review Oncology

Tumor Innervation: History, Methodologies, and Significance

James H. Baraldi, German Martyn, Galina Shurin, Michael R. Shurin

Summary: This comprehensive review summarizes the literature on tumor innervation, addressing the evidence, historical developments, and important mechanisms related to tumor development. It concludes that solid tumors are innervated and that nerves, neurons, and glia play a functional role in tumor development.

CANCERS (2022)

Review Oncology

Regulation of Carcinogenesis by Sensory Neurons and Neuromediators

Nuray Erin, Galina V. Shurin, James H. Baraldi, Michael R. Shurin

Summary: Sensory nerve fibers and the vagus nerve play crucial roles in tumor growth and spread. Current findings are contradictory, likely due to the stage and aggressiveness of the tumor model. Sensory neurons and Schwann cells are important players in tumor development, growth, and progression.

CANCERS (2022)

Article Oncology

A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells

Shuhui Cao, Yue Wang, Yan Zhou, Yao Zhang, Xuxinyi Ling, Lincheng Zhang, Jingwen Li, Yu Yang, Weimin Wang, Michael R. Shurin, Hua Zhong

Summary: This study demonstrates the role of tumor-associated Schwann cells in the progression of small-cell lung cancer by constructing a mRNA-miRNA-lncRNA network. The findings improve our understanding of the interaction between tumor cells and Schwann cells, and provide insights into cancer progression.

CANCERS (2022)

Article Cell Biology

Tumor-Induced T Cell Polarization by Schwann Cells

Galina Shurin, Kavita Vats, Oleg Kruglov, Yuri L. Bunimovich, Michael R. Shurin

Summary: Nerve-cancer crosstalk is controlled by Schwann cells, which can be stimulated by tumor cells to produce prostaglandin E. This inhibits the proliferation of activated T cells and leads to T cell exhaustion. Understanding this pathway is important for the development of cancer therapies.
Editorial Material Immunology

Immunological targets for cancer therapy: new recognition

Michael R. Shurin

IMMUNOTARGETS AND THERAPY (2018)

暂无数据